News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Fardis Maria
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2023 |
4
| Fardis Maria (Director) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 13,000 options to buy
@ $62.59, valued at
$813.7k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2020 |
4
| Fardis Maria (President and CEO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 1,894 shares
@ $33.12, valued at
$62.7k
|
|
| 05/04/2020 |
4
| Fardis Maria (President and CEO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 1,894 shares
@ $32, valued at
$60.6k
|
|
| 04/03/2020 |
4
| Fardis Maria (President and CEO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 1,494 shares
@ $27.94, valued at
$41.7k
|
|
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2020 |
4
| Fardis Maria (President and CEO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 1,302 shares
@ $22.54, valued at
$29.3k
|
|
| 01/07/2020 |
4
| Fardis Maria (President and CEO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Granted 500,000 options to buy
@ $25.54, valued at
$12.8M
|
|
| 01/06/2020 |
4
| Fardis Maria (President and CEO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 1,562 shares
@ $26.68, valued at
$41.7k
|
|
| 12/04/2019 |
4
| Fardis Maria (President and CEO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 1,894 shares
@ $21.97, valued at
$41.6k
Paid exercise price by delivering 1,894 shares
@ $22.66, valued at
$42.9k
|
|
| 12/04/2019 |
4
| Fardis Maria (President and CEO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 51,673 shares
@ $7.15, valued at
$369.5k
Paid exercise price by delivering 143,496 shares
@ $5.45, valued at
$782.1k
Paid exercise price by delivering 1,994 shares
@ $7.35, valued at
$14.7k
Paid exercise price by delivering 1,993 shares
@ $5.7, valued at
$11.4k
Paid exercise price by delivering 1,994 shares
@ $6, valued at
$12k
Paid exercise price by delivering 1,993 shares
@ $7.75, valued at
$15.4k
Paid exercise price by delivering 1,994 shares
@ $7.15, valued at
$14.3k
Paid exercise price by delivering 1,994 shares
@ $8.8, valued at
$17.5k
Paid exercise price by delivering 1,562 shares
@ $8, valued at
$12.5k
Paid exercise price by delivering 1,525 shares
@ $16.5, valued at
$25.2k
Paid exercise price by delivering 1,321 shares
@ $18.15, valued at
$24k
|
|
| 03/06/2019 |
4
| Fardis Maria (President and CEO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Granted 400,000 options to buy
@ $11.26, valued at
$4.5M
|
|
| 02/12/2018 |
4
| Fardis Maria (President and CEO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Granted 500,000 options to buy
@ $16.8, valued at
$8.4M
|
|
| 08/18/2016 |
4
| Fardis Maria (President and CEO) has filed a Form 4 on Lion Biotechnologies, Inc.|
Txns:
| Granted 35,000 options to buy
@ $9.1, valued at
$318.5k
|
|
| 06/09/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/17/2014 |
4
| Fardis Maria (Chief of Oncology Ops & Allian) has filed a Form 4 on PHARMACYCLICS INC|
Txns:
| Sold 3,000 shares
@ $141.3006, valued at
$423.9k
Exercised 3,000 options to buy
@ $6.84, valued at
$20.5k
|
|
| 11/10/2014 |
4
| Fardis Maria (Chief of Oncology Ops & Allian) has filed a Form 4 on PHARMACYCLICS INC|
Txns:
| Sold 5,000 shares
@ $134.5, valued at
$672.5k
Exercised 5,000 options to buy
@ $6.84, valued at
$34.2k
|
|
| 11/04/2014 |
4
| Fardis Maria (Chief of Oncology Ops & Allian) has filed a Form 4 on PHARMACYCLICS INC|
Txns:
| Acquired 1 shares
@ $80.9285, valued at
$80.9 |
|
| 08/15/2014 |
4
| Fardis Maria (Chief of Oncology Ops & Allian) has filed a Form 4 on PHARMACYCLICS INC|
Txns:
| Sold 4,000 shares
@ $121.01, valued at
$484k
Exercised 4,000 options to buy
@ $6.84, valued at
$27.4k
|
|
| 05/02/2014 |
4
| Fardis Maria (Chief of Oncology Ops & Allian) has filed a Form 4 on PHARMACYCLICS INC|
Txns:
| Acquired 204 shares
@ $80.39, valued at
$16.4k
|
|
| 04/04/2014 |
4
| Fardis Maria (Chief of Oncology Ops & Allian) has filed a Form 4 on PHARMACYCLICS INC|
Txns:
| Granted 40,000 options to buy
@ $102.22, valued at
$4.1M
|
|
| 03/07/2014 |
4
| Fardis Maria (Chief of Oncology Ops & Allian) has filed a Form 4 on PHARMACYCLICS INC|
Txns:
| Sold 3,000 shares
@ $140.5012, valued at
$421.5k
Exercised 3,000 options to buy
@ $6.84, valued at
$20.5k
|
|
| 05/01/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/07/2013 |
4
| Fardis Maria (EVP, Operations and Alliances) has filed a Form 4 on PHARMACYCLICS INC|
Txns:
| Exercised 3,500 shares
@ $6.84, valued at
$23.9k
Sold 3,500 shares
@ $64.2, valued at
$224.7k
Exercised 3,500 options to buy
@ $6.84, valued at
$23.9k
|
|
| 11/02/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/29/2012 |
4
| Fardis Maria (EVP, Operations and Alliances) has filed a Form 4 on PHARMACYCLICS INC|
Txns:
| Granted 50,000 options to buy
@ $61.6, valued at
$3.1M
|
|
|
|